Thomas Ried

37.4k total citations · 8 hit papers
378 papers, 27.8k citations indexed

About

Thomas Ried is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Thomas Ried has authored 378 papers receiving a total of 27.8k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Molecular Biology, 137 papers in Genetics and 113 papers in Oncology. Recurrent topics in Thomas Ried's work include Genomic variations and chromosomal abnormalities (112 papers), Cancer Genomics and Diagnostics (80 papers) and Genetic factors in colorectal cancer (64 papers). Thomas Ried is often cited by papers focused on Genomic variations and chromosomal abnormalities (112 papers), Cancer Genomics and Diagnostics (80 papers) and Genetic factors in colorectal cancer (64 papers). Thomas Ried collaborates with scholars based in United States, Germany and Sweden. Thomas Ried's co-authors include Evelin Schröck, Michael J. Difilippantonio, Hesed Padilla‐Nash, Stanislas du Manoir, Β. Michael Ghadimi, Gert Auer, Anthony Wynshaw‐Boris, André Nussenzweig, Jordi Camps and Marek Liyanage and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thomas Ried

372 papers receiving 27.3k citations

Hit Papers

Multicolor Spectral Karyotyping of Human Chromosomes 1996 2026 2006 2016 1996 1996 2008 2008 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multicolor Spectral Karyotyping of Human Chromosomes
    1996 1.3k citations Thomas Ried et al. profile →
  2. Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
    1996 1.2k citations Thomas Ried, Anthony Wynshaw‐Boris et al. profile →
  3. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
    2008 855 citations Hesed Padilla‐Nash, Thomas Ried et al. profile →
  4. Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
    2008 634 citations Thomas Ried et al. profile →
  5. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
    1999 595 citations Thomas Ried, Anthony Wynshaw‐Boris et al. profile →
  6. From Silencing to Gene Expression
    2004 569 citations Thomas Ried et al. profile →
  7. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
    1997 525 citations Thomas Ried et al. profile →
  8. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching
    2001 409 citations Michael J. Difilippantonio, Thomas Ried et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Ried United States 84 17.7k 7.3k 6.2k 6.2k 2.8k 378 27.8k
Alan D. D’Andrea United States 98 25.3k 1.4× 11.2k 1.5× 5.1k 0.8× 6.7k 1.1× 2.0k 0.7× 313 32.7k
Geoffrey M. Wahl United States 80 21.7k 1.2× 11.1k 1.5× 4.3k 0.7× 4.8k 0.8× 2.2k 0.8× 178 30.1k
Jeffrey M. Trent United States 89 20.5k 1.2× 7.3k 1.0× 6.1k 1.0× 5.9k 0.9× 989 0.4× 384 31.5k
Peter Lichter Germany 100 19.4k 1.1× 6.7k 0.9× 7.2k 1.2× 6.0k 1.0× 3.1k 1.1× 490 36.6k
William S. Lane United States 92 28.0k 1.6× 5.5k 0.8× 4.0k 0.6× 6.8k 1.1× 1.4k 0.5× 201 36.8k
Junjie Chen United States 93 26.9k 1.5× 9.8k 1.3× 4.0k 0.6× 6.6k 1.1× 1.3k 0.4× 387 32.5k
Kristian Helin Denmark 103 31.3k 1.8× 9.1k 1.2× 4.6k 0.7× 4.8k 0.8× 1.3k 0.5× 275 37.0k
Hiroyuki Aburatani Japan 98 24.4k 1.4× 8.4k 1.2× 3.6k 0.6× 7.6k 1.2× 1.1k 0.4× 531 38.1k
Michael R. Speicher Germany 64 10.0k 0.6× 5.7k 0.8× 4.2k 0.7× 6.5k 1.0× 2.2k 0.8× 177 19.1k
Olli Kallioniemi Finland 99 20.2k 1.1× 9.7k 1.3× 9.4k 1.5× 11.3k 1.8× 1.7k 0.6× 428 36.3k

Countries citing papers authored by Thomas Ried

Since Specialization
Citations

This map shows the geographic impact of Thomas Ried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ried more than expected).

Fields of papers citing papers by Thomas Ried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ried. The network helps show where Thomas Ried may publish in the future.

Co-authorship network of co-authors of Thomas Ried

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ried. A scholar is included among the top collaborators of Thomas Ried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ried. Thomas Ried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Haoyun, E. Michael Gertz, Alejandro A. Schäffer, et al.. (2021). Tumor heterogeneity assessed by sequencing and fluorescence in situ hybridization (FISH) data. Bioinformatics. 37(24). 4704–4711. 9 indexed citations
2.
Danforth, David N., Armando Filie, Andrew Warner, et al.. (2020). Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia. Cancer Prevention Research. 13(12). 1027–1036. 3 indexed citations
3.
Freitag‐Wolf, Sandra, Timo Gemoll, Kerstin Heselmeyer‐Haddad, et al.. (2020). Genome Instability Profiles Predict Disease Outcome in a Cohort of 4,003 Patients with Breast Cancer. Clinical Cancer Research. 26(17). 4606–4615. 9 indexed citations
4.
Emons, Georg, Melanie Spitzner, Noam Auslander, et al.. (2017). Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling. Molecular Cancer Research. 15(11). 1481–1490. 104 indexed citations
5.
Kidder, Benjamin L., Runsheng He, Darawalee Wangsa, et al.. (2017). SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation. Cancer Research. 77(23). 6729–6745. 27 indexed citations
6.
Chen, Haiming, Darawalee Wangsa, Jordi Camps, et al.. (2017). Nucleome Analysis Reveals Structure–Function Relationships for Colon Cancer. Molecular Cancer Research. 15(7). 821–830. 22 indexed citations
7.
Yang, Shouhui, Peijun He, Aaron J. Schetter, et al.. (2016). Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Clinical Cancer Research. 22(24). 5992–6001. 40 indexed citations
8.
Yang, Shouhui, Peijun He, Jian Wang, et al.. (2016). A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Cancer Research. 76(13). 3838–3850. 225 indexed citations
9.
Zhang, Geng, Peijun He, Anuradha Budhu, et al.. (2013). Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer. Clinical Cancer Research. 19(18). 4983–4993. 245 indexed citations
10.
Camps, Jordi, Jason J. Pitt, Georg Emons, et al.. (2013). Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/β-Catenin Pathway in Colorectal Cancer. Cancer Research. 73(6). 2003–2013. 69 indexed citations
11.
Gaedcke, Jochen, Marian Grade, Jordi Camps, et al.. (2012). The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa. Clinical Cancer Research. 18(18). 4919–4930. 158 indexed citations
12.
Hirsch, Daniela, Ralf Kemmerling, Sean Davis, et al.. (2012). Chromothripsis and Focal Copy Number Alterations Determine Poor Outcome in Malignant Melanoma. Cancer Research. 73(5). 1454–1460. 76 indexed citations
13.
To, Kenneth K.W., Robert W. Robey, Turid Knutsen, et al.. (2009). Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Molecular Cancer Therapeutics. 8(10). 2959–2968. 86 indexed citations
14.
15.
Grade, Marian, Β. Michael Ghadimi, Sudhir Varma, et al.. (2006). Aneuploidy-Dependent Massive Deregulation of the Cellular Transcriptome and Apparent Divergence of the Wnt/β-catenin Signaling Pathway in Human Rectal Carcinomas. Cancer Research. 66(1). 267–282. 44 indexed citations
16.
Chen, Kevin G., Yan C. Wang, Marci E. Schaner, et al.. (2005). Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. Cancer Research. 65(20). 9388–9397. 41 indexed citations
17.
Yakushiji, Hiroyuki, et al.. (2005). Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching. Cancer Research. 65(19). 8736–8746. 20 indexed citations
18.
Upender, Madhvi B., Jens K. Habermann, Lisa M. McShane, et al.. (2004). Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells. Cancer Research. 64(19). 6941–6949. 137 indexed citations
19.
Pack, Svetlana, Özgül M. Alper, Kurt Stromberg, et al.. (2004). Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line. Cancer Research. 64(3). 789–794. 27 indexed citations
20.
Montagna, Cristina, Eran R. Andrechek, Hesed Padilla‐Nash, William J. Muller, & Thomas Ried. (2002). Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene. 21(6). 890–898. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan D. D’Andrea Breakdown of academic impact, for papers by Geoffrey M. Wahl Breakdown of academic impact, for papers by Jeffrey M. Trent Breakdown of academic impact, for papers by Peter Lichter Breakdown of academic impact, for papers by William S. Lane Breakdown of academic impact, for papers by Junjie Chen Breakdown of academic impact, for papers by Kristian Helin Breakdown of academic impact, for papers by Hiroyuki Aburatani Breakdown of academic impact, for papers by Michael R. Speicher Breakdown of academic impact, for papers by Olli Kallioniemi
Rankless by CCL
2026